Novanta NOVT Medical Solutions — D&A

Similar metrics at other companies

MIRMedical Segment — D&A

$16.2M-1.2%

MKSIMaterials Solutions Division — D&A

$65M+4.8%

JNJMedical Devices — D&A

$903M+8.0%

UNFFirst Aid And Safety Solutions — D&A

$1.39M+46.5%

CSWEngineered Building Solutions — D&A

$488K+14.3%

BDXMedical — D&A

$348.25M+14.6%

Questions, answered.

What is Novanta's medical solutions — D&A?

Novanta (NOVT) reported medical solutions — D&A of $9.58M in Q1 2026.

How has Novanta's medical solutions — D&A changed year-over-year?

Novanta's medical solutions — D&A increased by 24.7% year-over-year, from $7.68M to $9.58M.

What is the long-term trend for Novanta's medical solutions — D&A?

Over 4 years (2021 to 2025), Novanta's medical solutions — D&A has grown at a 16.2% compound annual growth rate (CAGR), from $20.81M to $37.96M.

What does medical solutions — D&A mean?

This represents the total non-cash expense allocated to the wear and tear, obsolescence, or exhaustion of tangible and intangible assets over their useful lives. It is a critical component for calculating EBITDA and understanding the capital intensity of the segment's operations. Higher levels often indicate a larger base of fixed assets or significant recent investments in infrastructure.